Introduction
Natural infections of domestic cats with feline leukaemia virus (FeLV) often result in fatal neoplastic or degenerative diseases after a long incubation period (Jarrett, 1984; Nell & Onions, 1985) . In many cases the development of disease in FeLV-infected cats can be attributed to the evolution of variant FeLV forms with increased and highly specific pathogenicity. FeLV variants, which are frequently replication-defective, arise from the common infectious form of FeLV by recombination with cellular proto-oncogenes or proviral elements, or by more subtle mutational changes (Nell et al., 1991) .
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FeLV isolates were assigned to three subgroups, A, B or C (Sarma & Log, 1973) . These assays generally employ FeLV pseudotypes of murine sarcoma viruses and demonstrate that subgroup phenotype is a function of the viral envelope (Fischinger et al., 1974) . Interference is the resistance to superinfection by viruses that share the same receptor on feline cells and is assumed to result from the occupation of receptors by the corresponding viral gp70 env glycoprotein.
Subgroup A is the prevalent form of FeLV. It is present in all natural isolates, is efficiently transmitted between cats and appears to be minimally pathogenic in the absence of other FeLV variants. FeLV-B and FeLV-C are found along with FeLV-A in 40~ and 1 ~o of field cases, respectively, but are not readily transmissible by themselves (Russell & Jarrett, 1976) . FeLV-B env sequences demonstrate considerable divergence from FeLV-A, differing in five variable regions within gp70 (Neil et al., 1987) . The use of probes from these divergent M. A. Rigby and others env sequences showed that the FeLV-B env gene is derived from endogenous FeLV proviral DNA (Stewart et al., 1986) . This has subsequently been confirmed by direct sequence analysis of the endogenous proviral elements which recombine with FeLV-A (Kumar et al., 1989) . FeLV-B isolates have diverse pathogenic properties and are over-represented in leukaemic compared to healthy cats (Jarrett et al., 1978; Tzavaras et al., 1990) .
All isolates of FeLV-C have come from adult cats with non-regenerative anaemia (pure red cell aplasia). Biologically cloned FeLV-C isolates (Onions et al., 1982) and a molecular clone of the prototype, FeLV-C/Sarma (Riedel et al., 1986) , rapidly reproduce this disease (after approximately 6 weeks) on inoculation into newborn kittens. However, FeLV-C/Sarma is incapable of establishing infection in older cats unless inoculated directly into bone marrow (Dornsife et al., 1989) or co-infected with FeLV-A . The association of these in vivo and in vitro properties with viruses of subgroup C suggests that they are also determined by the viral env gene. Comparison of the env sequences of the prototype FeLV-C/Sarma (Luciw et al., 1985) with FeLV-A (Stewart et al., 1986; Luciw et al., 1985; Donahue et al., 1988) show a close similarity, with the differences clustered in three short variable regions (Vr) of env, Vrl, Vr4 and Vr5. The determinants of FeLV-C/ Sarma subgroup and disease phenotype have been studied by restriction fragment exchange between FeLV-C/Sarma and a minimally pathogenic FeLV-A; this study localized determinants of host range and disease type to a region consisting of the 3' pol and 5' env sequences , including the env Vrl domain.
In the present study the determinants of FeLV-C subgroup phenotype and host range were delineated further and were found to be localized to a single cysteine-bounded domain of gp70 encompassing Vrl. The sequence of this region varies amongst other naturally occurring subgroup C isolates suggesting that each has arisen independently from FeLV-A by mutation. Furthermore, these results suggest that apparently divergent primary sequence changes in the envelope glycoprotein can confer the same host cell surface receptor specificity.
Methods
Cell lines and culture. Feline fibroblast FEA cells (Jarrett et al., 1973) and baby hamster kidney suspension cells (BHK21S; Wellcome Biotechnoiogy) were maintained in SLM (Gibco). Feline T lymphoma cells (3201B; Snyder et al., 1978) and large granular lymphoma cells (MCC; Cheney et al., 1990) were maintained in a 1:1 (v/v) mixture of RPMI 1640 and Leibowitz L-15 medium as described by Rojko et al. (1989) . Canine osteosarcoma ceils (D-17), human rhabdomyosarcoma cells (RD) and guinea-pig fibroblasts (GP), all obtained from Drs J. Casey (Ithaca, N.Y., U.S.A.) and V. Hirsch (Gaithersburg, Md., U.S.A.), were maintained in Dulbecco's minimal essential medium as described by Riodel et al. (1986) . DNA transfection was by the calcium phosphate coprecipitation method (Graham & van der Eb, 1973) or by liposome cotransfection (Gibco-BRL).
FeLV isolates and proviral clones. The prototype FeLV-A and FeLV-C isolates were available in molecularly cloned form. These were the minimally pathogenic FeLV-A/Glasgow-1 (pFGA5; Stewart et al., 1986) and FeLV-C/Sarma, a virus originally derived from the FeLV-ABC/KT complex in the FL74 lymphoma cell line (pFSC; Riedel et al., 1986) . Infectious viruses were reconstituted from these proviral clones by transfection into FEA, BHK21S or D-17 cells. Five further isolates were available in biologically cloned form in infected FEA cell cultures. FeLV-A/Q182 is a component of the FeLV-ABC/KT complex. FeLV-A/GM-I is the helper virus from a myeloid leukaemogenic FeLV-AB complex, and was also available as a proviral molecular clone (Tzavaras et al., 1990) . FeLV-C/FA27, -C/FZ215 and -C/FS246 are anaemogenic isolates from, respectively, FeLV-AC, -ABC and -AC complexes and were isolated in a previous study by passage through GP cells (Onions et al., 1982) .
Polymerase chain reaction ( PCR) and sequence analysis. PCR analysis was performed on 1 ~tg of genomic DNA prepared from FEA cells infected with biologically cloned isolates of FeLV, or 0.01 ng of proviral plasmid clone. The 5' ends of the primers used correspond to positions 6122 and 6523 of FeLV-A/ll61E (Donahue et al., 1988) . The primer sequences were ATAACCAATGTACARACYAA (5' primer) and AGAGCTATTGTCCTGYRTACT (Y primer). PCR was carried out using commercial reagents (Cetus Corporation) using 30 cycles of 92 °C for 1 min, 50 °C for 1 rain, 72 °C for 1 min. PCR products were purified by phenol extraction and ethanol precipitation prior to cloning in to HincII-linearized pIC19R (Marsh et al., 1984) . Following transformation, recombinants were identified by colony hybridization using the Vrl probe and sequence analysis was by standard procedures.
Site-directed mutagenesis. Mutagenesis was done by the oligonucleotide method of Zoller & Smith (1982) applied to a 'gapped duplex' structure consisting of a single-stranded M13mpl8 subclone of Vrl from pFGA5 (MI3-FGA-H2H3; Fig. 1 ) annealed to wild-type M13mpl0 sequences. The mutagenic oligonucleotides used were (i) ACGTGCCCCGTGTTT-TGGGTTTAGGACTAT ('-' indicates the position of the three-codon deletion), (ii) CGTGTTTTGGGT_CT-GGGGCTATAGGTTCCC and (iii) AGTAACGTGCCCAGGA-TCTTGGGTCTGGGG (positions of mutations underlined); these sequentially introduced the deletion and point mutations that characterize the homologous FeLV-C/Sarma sequence. The nomenclature of the corresponding proviruses is indicated in Fig. 1 .
Virological assays. Virus detection by ELISA for FeLV p270~0 was performed with a commercial kit (IDEXX Corporation or TechAmerica). Virus infectivity titre was measured by the C81 focusformation assay (Fischinger et al., 1974) and the viral subgroup was determined by interference assay (Russell & Jarrett, 1976) . In vitro toxicity of FeLV isolates was determined in feline T lymphoma 3201B cells (Rojko et al., 1992) .
In vivo studies. One-day or 9-week old specific pathogen-free (SPF) kittens were inoculated by the intraperitoneal route with l0 s f.f.u. FeLV in cell culture superuatants. Kittens were monitored for the induction of viraemia by indirect immunofluorescence assay for FeLV p27 antigen in circulating leukocytes (Hardy et al., 1973) and by ELISA in serum at biweekly to monthly intervals. Haematological parameters were measured at 4, 9, 13 and 26 weeks post-inoculation. These consisted of complete blood counts (CBC), reticulocyte counts and in vitro assays for marrow precursor CFU-E (erythroid colony-forming Fig. 1 . Scheme for the generation of chimeric and engineered mutant FeLV proviruses. These proviruses were derived from the plasmid pFGA5, an infectious molecular clone of FeLV-A/Glasgow-1 (Stewart et al., 1986) which is illustrated at the top with relevant sites for restriction endonucleases EcoRI (R1), HinclI (H2), BamHI (B), HindlII (H3) and XhoI (Xh) indicated. Vrl (solid box) lies within a 247 bp HinclI-HindlII fragment (stippled box) in pFGA-5; the partial amino acid sequence of this segment is detailed underneath, along with the amino acid differences in (i) the mutants derived using mutagenic oligonucleotides 1, 2 and 3 (plasmids pV-A/C-1, -2 and -3), and (ii) the FeLV-C-derived homologues (pV-A/C-Sarma and -215). Only the variant amino acid positions are shown here. Complete sequences are shown in Fig. 2 . The reconstruction scheme used to produce the fulllength recombinant proviruses is illustrated in the upper part. The stippled area is the sequence domain exchanged in these constructs. The scheme involved successive subcloning and reconstruction using subgenomic cassettes defined by unique restriction sites which allowed simple directional cloning steps. Further details are given in the text. *, Plasmid vector pAT153 in which the EcoRI site was destroyed; #, plasmid vector plC19R in which the HinclI site was destroyed.
units), BFU-E (erythroid burst-forming units), CFU-GM (granulocyte-macrophage colony-forming units) and CFU-F (fibroblast colonyforming units) using feline spleen cell-conditioned medium as described by Kociba & Halper (1987) and Wellman et al. (1984) . Direct and indirect Coombs' tests for anti-erythrocyte antibodies were performed in the clinical haematology laboratory of the Ohio State University Hospital.
Results

Vr l-chimeric viruses are infectious and have the subgroup phenotype and in vitro host range of FeLV-C
Inspection of several FeLV-A env sequences and comparison with the prototype FeLV-C, FeLV-C/ Sarma, showed that Vrl is the site of greatest sequence divergence and the only position where the env coding sequences are non-collinear. Vrl is also within the 886 base pair pol-env fragment previously shown to encode FeLV-C subgroup determinants . This observation pinpointed Vrl as a possible site of subgroup-specific contact between the virion glycoprotein and host cell receptor. To examine whether switching Vrl alone was sufficient to modulate FeLV subgroups A to C, chimeric proviruses were constructed by exchanging the region delimited by the HinclI and HindlII sites of clone pFGA5 ( Fig. 1 ) which encompasses Vrl of FeLV-A/Glasgow-1 with the homologous regions of two subgroup C viruses, FeLV-C/Sarma and FeLV-C/FZ215. The FeLV-C fragments were generated by PCR using primers that introduced the necessary restriction sites without altering the coding potential and their sequences are shown in Fig. 1 . The full sequence of FeLV-C/FZ215 around this region is presented in Fig. 2 . The subcloning and reconstruction procotol is shown in diagrammatic form in Fig. 1 . A nested reconstruction scheme was used to incorporate the different Vrl fragments into the A/Glasgow-1 provirus. HinclIHindlII fragments were exchanged for wild-type sequences in a XhoI-HindlII subclone and this region was in turn incorporated into a larger clone that included all proviral sequences 3' to the XhoI site. Finally, sequences 5' to this site were added as an EcoRI-XhoI fragment from pFGA5, to give full-length proviral clones which were designated pVA/C-Sarma and pVA/C-215. The expected sequences at Vrl of each of these final constructs were confirmed by direct DNA sequencing of the proviral clones. FEA, BHK21S and D17 cells were transfected with wild-type and chimeric proviral plasmids and the spread of infectious virus through the culture was determined by p27 gag ELISA after 2 weeks and by infectivity on C81 cells (Russell & Jarrett, 1976) . The reconstructed FeLV-A/Glasgow-1 clone (pVA/C-0) and the two chimeric proviruses (pFGA/C-Sarma and pFGA/C-215) scored positive in both tests, as did cultures transfected with the parental plasmid pFGA-5 (Table 1) .
The viruses produced from cell cultures transfected with the chimeras were determined to be of subgroup C phenotype (Table 1) by interference assay (Russell & Jarrett, 1976 ), and they were tested for their ability to replicate in feline and heterologous cells. As shown in Table 1 , FeLV-A/Glasgow-1 replicated only in feline cells whereas FeLV-C/Sarma virus had an extended host range, replicating also in canine, guinea-pig and human cells, but not in feline large granular lymphoma cells (MCC). The two chimeric FeLV-A/C viruses had the same host range as FeLV-C/Sarma while retaining full competence for replication in feline cells including the cell line MCC (Table 1) . Stewart et al., 1986) , A/1161E (Donahue et al., 1988) , A/F3A (Donahue et al., 1988) and C/Sarma . The alignment spans the pFGA-5 restriction sites HinclI to HindlII shown in Fig. 1 [coordinates 6203 and:6455 of A/1161E; the amplified domain covered 6122 to 6523 (Donahue et al., 1988) ]. Nucleotide differences that do not alter the gp70 ~"v amino acid sequence are underlined. (b) Predicted gp7(F "~ Vr I amino acid sequences of wild-type and recombinant viruses. The alignment illustrates the predicted amino acid sequences from the DNA sequences presented in (a). In addition, the sequence of the site-directed mutant Vrl domain (A/C-3) is shown. Numbering corresponds to the env gene precursor polyprotein predicted from the sequence of pFGA-5 (FeLV-A/Glasgow-1 ; Stewart et al., 1986) . 
M. A. R~gby and others
Vrl-chimeric viruses are non-cytopathic in vitro
FeLV-C/Sarma, but not FeLV-A/Glasgow-1, replicates to high titre and induces apoptosis in feline T4 lymphoma cells (3201B) within 1 to 2 weeks of exposure MA 3/4 § 2.5 + 0.5 7.5 + 2-011 6/6 A/C-215 10/11 1.7 MA t0/ll § 2.5 +0.5 6.5 + 2"011 6/6 C/Sarma 3/5 5.0 AA 2/5 2.0 + 1.0 3.0 _ 0 0/4 MA 1/5 4 >6 * Focus-forming units ( x 10 -4) per ml plasma in C81 assay (Fischinger et aL, 1974) . t AA, aplastic anaemia; MA, macrocytic anaemia. :~ One of four cachexic at 7 months. § One of four and five of 11 also developed lymphoma at 5 to 9 months post-inoculation. II Different at P < 0.05 from C/Sarma, A/Glasgow-I and uninfected controls by Mann-Whitney unequal sample (pairs) test.
(Rojko et al., 1992). The determinants of this cytopathic effect have not previously been mapped although the long terminal repeat (LTR) has been implicated by reporter gene assays which show that the FeLV-C/Sarma LTR is severalfold more active in 3201B cells than that of
FeLV-A/Glasgow-1 (Rojko et al., 1992) . To determine whether cytopathicity of FeLV-C/Sarma is closely linked to subgroup C phenotype, the two chimeric viruses were tested for their ability to induce apoptosis in 3201 cells. As shown in Table 1 , neither of the chimeric viruses replicated well in, or killed, 3201B cultures and thus behaved like FeLV-A strains rather than FeLV-C/Sarma in this assay.
Vrl-chimeric FeLV are infectious for weanling cats and induce a form of anaemia distinct from that induced by FeL V-A and -C subgroup parental viruses
The most striking feature of FeLV-C infection in vivo is the induction of rapidly fatal non-regenerative anaemia where erythroid development past the BFU-E stage is completely abolished (Hoover et al., 1974; Mackey et al., 1975) . This disease phenotype was reproduced by a series of natural FeLV-C isolates including those for which the env sequences are presented in Fig. 2 (Onions et al., 1982) . Despite its pathogenic potential, FeLV-C/Sarma is strongly age-restricted for infection of cats. Unless introduced directly to bone marrow or co-infected with FeLV-A it can establish infection successfully only in neonatal animals Jarrett, 1981; Dornsife et al., 1989) . It was interesting, therefore, to examine the capacity of the Vrl chimeric viruses to establish infection and to induce characteristic FeLV-C disease.
One-day and 9-week old (weanling) kittens were inoculated with cell culture supernatants containing 105 f.f.u, of wild-type or chimeric viruses. Non-feline cells were used as the source of these viruses to avoid the possibility of in vitro recombination with endogenous FeLV sequences to produce subgroup B viruses (Overbau~h et al., 1988) . FeLV-A/Glas~ow-1, the FeLV-A/C chimeras and FeLV-C/Sarma all induced viraemia in neonates. The Vrl chimeras also induced viraemia in 12 of 12 weanlings, as shown in Table 2 . This behaviour is similar to that of FeLV-A, whereas FeLV-C/Sarma does not induce viraemia in kittens of this age, a property confirmed by this study (Table 2) .
Cats inoculated with FeLV-A/Glasgow-1 (produced by transfection of the reconstructed pVA/C-0) as neonates showed little sign of disease over the 14 month observation period and bone marrow cultures derived from them showed only a persistent decrease in CFU-GM (data not shown). Two of three cats viraemic with FeLV-C/Sarma developed normocytic, normochromic anaemia with markedly decreased levels of marrow erythroid precursors which was fatal within 1 to 3 months of infection, as seen in previous studies (Onions et al., 1982; Boyce et aL, 1981 ; Kociba & Halper, 1987; Riedel et al., 1986 Riedel et al., , 1988 . The third FeLV-C/Sarmainoculated kitten developed a macrocytic anaemia, resembling that induced by the chimeric viruses described below.
The chimeric viruses FeLV-A/C-Sarma and -A/C-215 induced a profound regenerative anaemia in neonates within 2 to 7 months, characterized by persistent macrocytosis and intermittent reticulocytosis, which was fatal within 5 to 8 months (Table 2) . Marrow colonyforming assays of FeLV-A/C-215-inoculated cats showed an increased frequency of BFU-E outside the normal reference range within 2 to 3 months of infection and terminal decreases in BFU-E and CFU-E (Table 3) , similar to changes seen in C/Sarma-infected cats (Riedel et al., 1986; Abkowitz et al., 1985; Wellman et al., 1984) . CFU-F numbers appeared normal but there were persistent decreases in CFU-GM from 1 month. Direct and indirect Coombs' tests for anti-erythrocyte antibodies were negative in the 13 kittens tested. * Samples taken at post-mortem apart from A/Glasgow-1 and uninfected control cats which were sampled at 9 weeks. t Different at P < 0-05 from uninfected cat and FeLV-A/Glasgow-1 controls by Mann-Whitney unequal samples (pairs) test. ~: Different at P < 0.05 from uninfected cat controls by Mann-Whitney unequal samples (pairs) test.
Samples of plasma or bone marrow from cats infected with the chimeric viruses were inoculated into FEA and D-17 cells. Analysis of these cultures by PCR and direct DNA sequencing confirmed that no changes had occurred at Vrl of the chimeras in vivo. Fig. 3 shows the PCR amplification of Vrl fragments from infected cats where the natural length variation is clearly retained.
FeL V proviruses with mutagenic intermediate Vr l sequences have a disabled phenotype
In an attempt to define the minimal change in FeLV-A Vrl sequence required to confer subgroup C phenotype, proviruses having Vrl sequences intermediate between those of FeLV-A/Glasgow-1 and FeLV-C/Sarma were generated by oligonucleotide-directed mutagenesis of pFGA5. The HinclI-HindlII fragment of FeLV-A/ Glasgow-1 was subcloned into M13 and subjected to oligonucleotide-directed mutagenesis to produce the sequential intermediates shown in Fig. 1 . The HinclIHindlII fragments were re-sequenced after mutagenesis to confirm that the appropriate changes had been introduced. The reconstruction protocol was exactly as for the chimeric viruses. The HinclI-HindlII fragments were cloned into the pFGA-5 backbone in a series of directional cloning steps. The sequences of reconstructed viruses were further confirmed by sequencing the plasmid DNA after manipulation. The control here was the wild-type FeLV-A HinclI-HindlII fragment reinserted by the same protocol to give pVA/C-0. This together with the unique sequences of the Vrl intermediate mutants pVA/C-1, -2 and -3 are shown in Fig. 1 . FEA cells were transfected with the recombinant proviral DNAs. Transfection with pVA/C-0 yielded FeLV of subgroup A and a titre similar to that of wildtype virus, whereas no infectious virus was isolated from FEA cells transfected with any 6f the mutant series. Apart from the control of the reconstructed FeLV-A/ Glasgow-1 (pA/C-0), the possibility that extraneous mutations had been introduced during reconstruction has been examined by isolation of single cell clones (BHK21S) transfected with each plasmid DNA. Nonfeline cells were used as recipients to exclude the possibility of rescue by recombination with endogenous FeLV-related proviruses . Analysis of these clones confirmed that each provirus encoded immunoprecipitable gag and env products of the expected sizes and hence were not obviously defective due to unintended changes (Rigby, 1989) .
Comparison of the coding sequences of mutant FeLV-A/C-3 and FeLV-C/Sarma (Fig. 2b) shows four residual amino acid differences which were left unchanged in the final mutant. Of these, the distal pair (Leu to Met and His to Tyr at residues 132 and 138 of FeLV-A, respectively) are most likely irrelevant to subgroup determination since they occur also in FeLV-A/ Q182, and because FeLV-C/FZ215 matches FeLV-A/ Glasgow-1 at these positions. The remaining two differences (LysTyr to ThrHis) lie much closer to the residues altered in the Vrl-mutant proviruses and seem more likely to play an important role in defining the minimal change necessary to generate a functional FeLV-C/Sarma-like virus.
Naturally occurring FeL V-C isolates are distinct from FeLV-A but are heterogeneous at Vrl
Analysis of the Vrl sequences of independent, naturally occurring FeLV-C isolates was undertaken to shed further light on the sequence requirements for subgroup C specificity. The corresponding region of DNA from each of several biologically cloned FeLV-A and -C isolates was isolated by PCR amplification of genomic DNA preparations from FEA cells infected with each isolate. Specificity of the reaction was confirmed by hybridization of the products to a Vrl probe (the 247 bp HinclI-HindlII restriction fragment of pFGA5); DNA from uninfected cells was negative in PCR by this criterion (data not shown).
The PCR products were cloned into the HinclI site of the plasmid plCI9R prior to DNA sequence analysis. DNA and amino acid alignments of the region spanning Fig. 2 (a) and (b) respectively; noncoding changes are underlined in Fig. 2(a) . The subgroup A isolates were found to be very similar to A/Glasgow-I (96.0 and 99.2~o nucleotide identity, 97.5 and 98.89/00 amino acid identity for A/Q182 and A/GM1, respectively). In contrast, the subgroup C isolates demonstrated much more variation (91.5 to 94"0~o nucleotide identity, 85.0 to 85.5~ amino acid identity with A/Glasgow-l) and showed clustering of mutations around Vrl. All the FeLV-C isolates show length heterogeneity at Vrl compared with FeLV-A: C/FZ215 and C/FA27 exhibit a three codon deletion as does C/Sarma, whereas C/FS246 has two separate insertions of D N A triplets which occur at regions of repeated G G C and CTC motifs. The subgroup C isolates all have isolate-specific changes clustered at Vrl, which may now be more narrowly defined as a domain of some 30 amino acids flanked by cysteine residues that are conserved amongst all the subgroup A and C sequences characterized. The FS246/C sequence is quite distinct from the other subgroup C isolates and precludes the definition of a simple subgroup C-specific motif at Vrl. Nevertheless, some common features can be discerned, most notably the introduction of additional hydrophobic residues immediately C-terminal to the deletions/insertions relative to FeLV-A.
Discussion
We have shown here that substitution of gp70 e"v sequences at Vrl is sufficient to convert FeLV-A/ Glasgow-I to a virus that has subgroup C interference properties in feline cells. FeLV-C Vrl also confers on FeLV-A the ability to infect guinea-pig cells, strongly suggesting that the receptor molecule on these heterologous cells is structurally related to the feline FeLV-C receptor. The demonstration of a single, subgroupdetermining domain for FeLV-A and -C presents a contrast to avian leukosis viruses, where the receptor specificity of subgroups B and E appears to involve two or more domains of the surface glycoprotein (Dorner et al., 1985; Dorner & Coffin, 1986) and to murine type C retroviruses where interference determinants have been reported to involve large regions of gp70 (Ottet al., 1990) . It is conceivable that regions of FeLV gp70 other than Vrl are also involved in receptor binding, but that these are conserved between FeLV-A and -C. A corollary of this proposal would be that the FeLV-A and -C receptors are themselves structurally related. The minimal sequence change necessary to modulate subgroup was addressed using Vrl-mutant proviruses with intermediate sequences but all of these proved to be replication-defective. In view of the control experiments performed it is highly improbable that the failure of these mutants to produce infectious FeLV was due to irrelevant spontaneous mutations arising during their construction. A more likely explanation of their defectiveness is that further sequence changes within Vrl are necessary to generate a fully functional FeLV-C. Two adjacent amino acid substitutions (LysTyr to Ile/ThrHis) 10 residues downstream of the FeLV-C/Sarma-specific deletion are implicated since these are the only shared features of the two functional chimeric FeLV-C viruses FeLV-A/C-Sarma and FeLV-A/C-215. Another possibility, however, is that the order in which the sitedirected mutations were introduced did not reflect the natural mutational order in the genesis of FeLV-C/ Sarma and that some or all of the amino acid substitutions preceded the deletion at Vrl. Further mutated intermediates would have to be constructed to determine which explanation is correct. It should also be borne in mind that FeLV-C isolates are invariably isolated in the presence of FeLV-A (Jarrett et al., 1978) and that the weakly pathogenic prototype FeLV-A may act as a helper virus and aid the spread of nascent FeLV-C by pseudotyping or genomic masking (Jarrett et al., 1984) .
The sequences presented in Fig. 2 (b) confirm previous reports of strong sequence conservation among diverse subgroup A isolates (Donahue et al., 1988) . From the results presented here, we might speculate that Vrl conservation in FeLV-A viruses reflects a requirement for optimal receptor affinity. Diverse FeLV-C isolates have a strong preponderance of non-synonymous mutations at Vrl, suggesting that it is the virion glyco-protein structure which is under selection, presumably for affinity for the subgroup C receptor. Perhaps the most surprising outcome of the analysis of natural FeLV-C isolates is the variability of sequence at Vrl, and the lack of a sequence pattern common to all the FeLV-C isolates despite their use of a common receptor. Also, the data clearly support the notion that each FeLV-C arose independently by mutation from FeLV-A.
Although Vrl appears to be sufficient to switch receptor preference, changes at Vrl do not fully account for the behaviour of FeLV-C/Sarma. For example, the ability of FeLV-C/Sarma to induce apoptosis of 3201B T lymphoma cells appears to be determined by sequences elsewhere in the genome. The level of expression of viral proteins may be involved since the FeLV-C/ Sarma LTR is severalfold more active in 3201B cells than that of FeLV-A/Glasgow-1 and this is correlated with the levels of virus produced (Rojko et al., 1992) . Alternatively, there are other variable domains of gp70 ~"v (e.g. Vr5) where FeLV-C/Sarma and FeLV-A/Glasgow-1 differ. Sequence changes close to Vr5 have been shown to play a role in T cell killing by FeLV-FAIDS, a defective FeLV variant (Donahue et al., 1991) .
The in vivo properties of the A/C chimeras also differ substantially from those of FeLV-C/Sarma. The chimeras, like FeLV-A, efficiently induce viraemia in weanling kittens and, like FeLV-C, induce anaemia in neonates. However, the anaemia induced by the chimeras is qualitatively different from that usually induced by FeLV-C/Sarma, being distinguished by its delayed progression, its macrocytic nature and its association with depletion of non-erythroid as well as erythroid lineages in bone marrow. This less rapidly fatal form of anaemia is an uncommon sequel to FeLV-C/Sarma infection but occurred in this study in one cat inoculated with FeLV-C/Sarma. It has also been recorded in FeLV-C/Sarma-infected hybrids between domestic cats and Geoffroy's cat (Abkowitz et al., 1987) suggesting that it may be a feature of less virulent viruses and/or more resistant host animals. It is interesting to compare the chimeric viruses we have generated here to that of Riedel and co-workers who substituted a much larger 886 bp pol-env fragment of FeLV-A/II61E with the homologous segment of FeLV-C/Sarma . That chimera [E-E-(SE)-E] appeared to induce disease more typical of FeLV-C/Sarma. It is possible that the larger fragment contains further important determinants or alternatively that sequences in the FeLV-A recombinant partners used (FeLV-A/Glasgow-1 vs FeLV-A/1161E) play a role in pathogenesis.
The Vrl chimeric viruses clearly dissociate subgroup phenotype from a well-established property of FeLV-C/ Sarma, its age-restricted infectivity for cats Jarrett, 1981) . It should be cautioned that other FeLV-C isolates, including previously constructed chimeras, have not been tested in weanling animals in this way and hence it is not clear whether this restricted growth property is significantly correlated with virus subgroup. However, a general observation which is borne out by this study is that the most highly pathogenic FeLV forms are incompetent for in vivo infection and replication unless the cats are very young or infection is aided by the more innocuous FeLV-A. The determinants of disease potential cannot therefore be mapped to a single genome. This appears to be a paradigm for the FeLV system (Neil et al., 1991) and may also be an important but overlooked or underemphasized feature of the pathogenesis of other retroviruses.
